{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:19:32Z","timestamp":1788347972531,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Expo Sci Environ Epidemiol"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Environmental exposure biomonitoring commonly requires a laboratory blood draw followed by processing, frozen storage, and transport of plasma or serum. Self-collection of blood onto matrices that are stable at ambient temperatures is an attractive approach for the measurement of circulating environmental chemicals.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To validate the measurement of per- and polyfluoroalkyl substances (PFAS) in capillary whole blood (WB) collected and dried onto a paper matrix using the Drawbridge Health OneDraw device. To explore sources of personal and environmental PFAS exposure in Veterans receiving care at the Central Arkansas Veterans Healthcare System (CAVHS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>PFAS concentrations in dried capillary WB collected with the OneDraw device were compared to matched venous blood plasma PFAS concentrations in 133 Veterans receiving care at the CAVHS. PFAS were quantified using ultra-high-performance liquid chromatography\/tandem mass spectrometry (UHPLC-MS\/MS). Associations between subjects\u2019 demographic characteristics, self-reported exposure factors, and PFAS concentrations in dried capillary WB were assessed. Geometric mean PFAS concentrations were visualized by subjects\u2019 county of residence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Measurement of 27 PFAS in dried capillary WB on OneDraw collection strips was robust with limits of quantification of 0.1\u2009ng\/mL for most analytes. In 133 Veterans, dried capillary WB levels of 10 PFAS were strongly correlated with venous blood plasma PFAS levels. WB PFAS concentrations were lower than venous blood plasma PFAS concentrations, reflecting selective partitioning of these compounds into plasma versus blood cells. WB concentrations of four PFAS (PFOA, PFOS, PFHxS, and PFNA) varied by sex and age at the time of blood draw and were associated with the primary source of drinking water.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance<\/jats:title>\n                    <jats:p>WB samples collected onto dried paper matrices, are a practical and scalable alternative to conventional venous blood draws for PFAS biomonitoring. This approach facilitates remote, repeated sampling without the need for clinical infrastructure, enabling broader participation in exposure studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Impact statement<\/jats:title>\n                    <jats:p>\n                      <jats:list list-type=\"bullet\">\n                        <jats:list-item>\n                          <jats:p>Tracking environmental exposures in military, occupational, and community contexts has been challenging, particularly due to the lack of a practical workflow for capturing biological samples without a clinical infrastructure. This has led to a reduced ability to capture personal exposure data, in turn, limiting the analyses of the impact of these exposures on long-term health. We developed and validated a robust method using a self-contained, blood collection device for PFAS exposure biomonitoring as a proof-of-concept for broader adoption of this approach to enable larger-scale, longitudinal studies of exposure to PFAS and other classes of environmental chemicals. This method can be used to improve the evaluation of exposure-outcome relationships and provides a foundation for evidence-based policy decisions for health care and benefits.<\/jats:p>\n                        <\/jats:list-item>\n                      <\/jats:list>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41370-026-00884-5","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:18:00Z","timestamp":1777547880000},"page":"878-887","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Use of a capillary blood collection device to monitor exposure to per- and polyfluoroalkyl substances (PFAS) in Veterans living in proximity to potential sources of environmental contamination"],"prefix":"10.1038","volume":"36","author":[{"given":"Lauren A.","family":"Havens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth R.","family":"Heitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsie R.","family":"Hartley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LeiAn","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne E.","family":"Fenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridoula","family":"Maraka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terra D.","family":"Vincent-Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"884_CR1","doi-asserted-by":"crossref","unstructured":"Panieri E, Baralic K, Djukic-Cosic D, Buha Djordjevic A, Saso L. PFAS molecules: a major concern for human health and the environment. Toxics 2022;10:44.","DOI":"10.3390\/toxics10020044"},{"key":"884_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2025.109589","volume":"202","author":"M Pavuk","year":"2025","unstructured":"Pavuk M, Adgate JL, Bartell SM, Bell E, Brown LM, Laumbach RJ, et al. Multi-site study of communities with PFAS-contaminated drinking water: methods, demographics, and PFAS serum concentrations. Environ Int. 2025;202:109589.","journal-title":"Environ Int"},{"key":"884_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.envint.2013.06.004","volume":"59","author":"F P\u00e9rez","year":"2013","unstructured":"P\u00e9rez F, Nadal M, Navarro-Ortega A, F\u00e0brega F, Domingo JL, Barcel\u00f3 D, et al. Accumulation of perfluoroalkyl substances in human tissues. Environ Int. 2013;59:354\u201362.","journal-title":"Environ Int"},{"key":"884_CR4","unstructured":"National Academies of Sciences E, Medicine, Health, Medicine D, Division on E, Life S, et al. The National Academies Collection: Reports funded by National Institutes of Health. In: Guidance on PFAS Exposure, Testing, and Clinical Follow-Up; doi 10.17226\/26156. National Academies Press (US) Copyright 2022 by the National Academy of Sciences. All rights reserved: Washington, 2022."},{"key":"884_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2020.110690","volume":"194","author":"K Steenland","year":"2021","unstructured":"Steenland K, Winquist A. PFAS and cancer, a scoping review of the epidemiologic evidence. Environ Res. 2021;194:110690.","journal-title":"Environ Res"},{"key":"884_CR6","doi-asserted-by":"publisher","first-page":"e535","DOI":"10.1016\/S2542-5196(22)00090-0","volume":"6","author":"R Fuller","year":"2022","unstructured":"Fuller R, Landrigan PJ, Balakrishnan K, Bathan G, Bose-O\u2019Reilly S, Brauer M, et al. Pollution and health: a progress update. Lancet Planet Health. 2022;6:e535\u2013e547.","journal-title":"Lancet Planet Health"},{"key":"884_CR7","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1126\/science.aay3164","volume":"367","author":"R Vermeulen","year":"2020","unstructured":"Vermeulen R, Schymanski EL, Barab\u00e1si AL, Miller GW. The exposome and health: where chemistry meets biology. Science. 2020;367:392\u20136.","journal-title":"Science"},{"key":"884_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2024.109117","volume":"194","author":"KH Kee","year":"2024","unstructured":"Kee KH, Seo JI, Kim SM, Shiea J, Yoo HH. Per- and polyfluoroalkyl substances (PFAS): trends in mass spectrometric analysis for human biomonitoring and exposure patterns from recent global cohort studies. Environ Int. 2024;194:109117.","journal-title":"Environ Int"},{"key":"884_CR9","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1289\/ehp.7617","volume":"113","author":"DB Barr","year":"2005","unstructured":"Barr DB, Wang RY, Needham LL. Biologic monitoring of exposure to environmental chemicals throughout the life stages: requirements and issues for consideration for the National Children\u2019s Study. Environ Health Perspect. 2005;113:1083\u201391.","journal-title":"Environ Health Perspect"},{"key":"884_CR10","doi-asserted-by":"crossref","unstructured":"Sonnenberg NK, Ojewole AE, Ojewole CO, Lucky OP, Kusi J. Trends in serum per- and polyfluoroalkyl substance (PFAS) concentrations in teenagers and adults, 1999\u20132018 NHANES. Int J Environ Res Public Health. 2023;20:6984.","DOI":"10.3390\/ijerph20216984"},{"key":"884_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1177\/1357633X221093434","volume":"30","author":"A Koulman","year":"2024","unstructured":"Koulman A, Rennie KL, Parkington D, Tyrrell CS, Catt M, Gkrania-Klotsas E, et al. The development, validation and application of remote blood sample collection in telehealth programs. J Telemed Telecare. 2024;30:731\u20138.","journal-title":"J Telemed Telecare"},{"key":"884_CR12","doi-asserted-by":"publisher","first-page":"13388","DOI":"10.1021\/acs.est.7b03299","volume":"51","author":"S Poothong","year":"2017","unstructured":"Poothong S, Thomsen C, Padilla-Sanchez JA, Papadopoulou E, Haug LS. Distribution of novel and well-known poly- and perfluoroalkyl substances (PFASs) in human serum, plasma, and whole blood. Environ Sci Technol. 2017;51:13388\u201396.","journal-title":"Environ Sci Technol"},{"key":"884_CR13","doi-asserted-by":"publisher","first-page":"7950","DOI":"10.1021\/acs.est.2c09852","volume":"57","author":"CC Carignan","year":"2023","unstructured":"Carignan CC, Bauer RA, Patterson A, Phomsopha T, Redman E, Stapleton HM, et al. Self-collection blood test for PFASs: comparing volumetric microsamplers with a traditional serum approach. Environ Sci Technol. 2023;57:7950\u20137.","journal-title":"Environ Sci Technol"},{"key":"884_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.envres.2025.120916","volume":"270","author":"JC Botelho","year":"2025","unstructured":"Botelho JC, Kato K, Wong LY, Calafat AM. Per- and polyfluoroalkyl substances (PFAS) exposure in the U.S. population: NHANES 1999-March 2020. Environ Res. 2025;270:120916.","journal-title":"Environ Res"},{"key":"884_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2022.156891","volume":"842","author":"RB Jain","year":"2022","unstructured":"Jain RB, Ducatman A. Serum concentrations of selected perfluoroalkyl substances for US females compared to males as they age. Sci Total Environ. 2022;842:156891.","journal-title":"Sci Total Environ"},{"key":"884_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05422-1","volume":"15","author":"V Berg","year":"2025","unstructured":"Berg V, Charles DD, Huber S, N\u00f8st TH, Sandanger TM, Averina M, et al. Temporal changes in per and polyfluoroalkyl substances and their associations with type 2 diabetes. Sci Rep. 2025;15:22026.","journal-title":"Sci Rep"},{"key":"884_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2025.109590","volume":"201","author":"CJ Chang","year":"2025","unstructured":"Chang CJ, Young AS, Keil A, Mullins CE, Liang D, Zhao S, et al. Novel and legacy per- and polyfluoroalkyl substances in humans: long-term temporal variability and metabolic perturbations. Environ Int. 2025;201:109590.","journal-title":"Environ Int"},{"key":"884_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2025.144297","volume":"376","author":"AM Ingelido","year":"2025","unstructured":"Ingelido AM, Abballe A, Dellatte E, Ferri F, Iacovella N, Marra V, et al. Ten years of PFOS and PFOA human biomonitoring in Italy: exposure levels and determinants of exposure. Chemosphere. 2025;376:144297.","journal-title":"Chemosphere"},{"key":"884_CR19","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1021\/acs.est.4c08701","volume":"59","author":"X Li","year":"2025","unstructured":"Li X, Hou M, Zhang F, Ji Z, Cai Y, Shi Y. Per- and polyfluoroalkyl substances and female health concern: gender-based accumulation differences, adverse outcomes, and mechanisms. Environ Sci Technol. 2025;59:1469\u201386.","journal-title":"Environ Sci Technol"},{"key":"884_CR20","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1021\/acs.est.1c04795","volume":"56","author":"PB McMahon","year":"2022","unstructured":"McMahon PB, Tokranov AK, Bexfield LM, Lindsey BD, Johnson TD, Lombard MA, et al. Perfluoroalkyl and polyfluoroalkyl substances in groundwater used as a source of drinking water in the eastern United States. Environ Sci Technol. 2022;56:2279\u201388.","journal-title":"Environ Sci Technol"},{"key":"884_CR21","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1126\/science.ado6638","volume":"386","author":"AK Tokranov","year":"2024","unstructured":"Tokranov AK, Ransom KM, Bexfield LM, Lindsey BD, Watson E, Dupuy DI, et al. Predictions of groundwater PFAS occurrence at drinking water supply depths in the United States. Science. 2024;386:748\u201355.","journal-title":"Science"},{"key":"884_CR22","doi-asserted-by":"publisher","first-page":"428","DOI":"10.2166\/wp.2019.205","volume":"21","author":"K Bowen","year":"2019","unstructured":"Bowen K, Krishna T, Backer L, Hodgins K, Waller LA, Gribble MO. State-level policies concerning private wells in the United States. Water Policy. 2019;21:428\u201335.","journal-title":"Water Policy"},{"key":"884_CR23","doi-asserted-by":"crossref","unstructured":"Colley SK, Kane PKM, MacDonald Gibson J. Risk communication and factors influencing private well testing behavior: a systematic scoping review. Int J Environ Res Public Health 2019;16:4333.","DOI":"10.3390\/ijerph16224333"},{"key":"884_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2021.150448","volume":"806","author":"R Mulhern","year":"2022","unstructured":"Mulhern R, Grubbs B, Gray K, MacDonald Gibson J. User experience of point-of-use water treatment for private wells in North Carolina: implications for outreach and well stewardship. Sci Total Environ. 2022;806:150448.","journal-title":"Sci Total Environ"},{"key":"884_CR25","doi-asserted-by":"crossref","unstructured":"Woodward EE, Hladik ML, Orlando JL, Uychutin M, Gray JL, Kolpin DW Assessing Pesticide Application Contributions of Per- and Polyfluoroalkyl Substances (PFAS) in Agricultural Streams. Environ Sci Technol Lett. 2026;13:586\u201393.","DOI":"10.1021\/acs.estlett.6c00132"},{"key":"884_CR26","doi-asserted-by":"publisher","first-page":"e0294134","DOI":"10.1371\/journal.pone.0294134","volume":"18","author":"TA Berthold","year":"2023","unstructured":"Berthold TA, McCrary A, deVilleneuve S, Schramm M. Let\u2019s talk about PFAS: inconsistent public awareness about PFAS and its sources in the United States. PLoS ONE. 2023;18:e0294134.","journal-title":"PLoS ONE"},{"key":"884_CR27","doi-asserted-by":"publisher","first-page":"e226257","DOI":"10.1001\/jamanetworkopen.2022.6257","volume":"5","author":"R Gasiorowski","year":"2022","unstructured":"Gasiorowski R, Forbes MK, Silver G, Krastev Y, Hamdorf B, Lewis B, et al. Effect of plasma and blood donations on levels of perfluoroalkyl and polyfluoroalkyl substances in firefighters in Australia: a randomized clinical trial. JAMA Netw Open. 2022;5:e226257.","journal-title":"JAMA Netw Open"},{"key":"884_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.chroma.2023.464522","volume":"1713","author":"JM Partington","year":"2024","unstructured":"Partington JM, Marchiandi J, Szabo D, Gooley A, Kouremenos K, Smith F, et al. Validating blood microsampling for per- and polyfluoroalkyl substances quantification in whole blood. J Chromatogr A. 2024;1713:464522.","journal-title":"J Chromatogr A"},{"key":"884_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.163530","volume":"883","author":"EZ Lin","year":"2023","unstructured":"Lin EZ, Nason SL, Zhong A, Fortner J, Godri Pollitt KJ. Trace analysis of per- and polyfluorinated alkyl substances (PFAS) in dried blood spots - demonstration of reproducibility and comparability to venous blood samples. Sci Total Environ. 2023;883:163530.","journal-title":"Sci Total Environ"},{"key":"884_CR30","doi-asserted-by":"publisher","first-page":"5671","DOI":"10.1007\/s00216-024-05484-6","volume":"416","author":"M Galletto","year":"2024","unstructured":"Galletto M, Ververi C, Massano M, Alladio E, Vincenti M, Salomone A. Development and validation of the UHPLC-MS\/MS method for the quantitative determination of 25 PFAS in dried blood spots. Anal Bioanal Chem. 2024;416:5671\u201387.","journal-title":"Anal Bioanal Chem"},{"key":"884_CR31","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/s41370-023-00603-4","volume":"33","author":"AK Rosen Vollmar","year":"2023","unstructured":"Rosen Vollmar AK, Lin EZ, Nason SL, Santiago K, Johnson CH, Ma X, et al. Per- and polyfluoroalkyl substances (PFAS) and thyroid hormone measurements in dried blood spots and neonatal characteristics: a pilot study. J Expo Sci Environ Epidemiol. 2023;33:737\u201347.","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"884_CR32","doi-asserted-by":"publisher","first-page":"12793","DOI":"10.1021\/acs.langmuir.7b02297","volume":"33","author":"AY Kostritskii","year":"2017","unstructured":"Kostritskii AY, Tolmachev DA, Lukasheva NV, Gurtovenko AA. Molecular-level insight into the interaction of phospholipid bilayers with cellulose. Langmuir. 2017;33:12793\u2013803.","journal-title":"Langmuir"},{"key":"884_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2023.115383","volume":"230","author":"X Guo","year":"2023","unstructured":"Guo X, Zhou L, Wang Y, Suo F, Wang C, Zhou W, et al. Development of a fast and robust liquid chromatography-mass spectrometry-based metabolomics analysis method for neonatal dried blood spots. J Pharm Biomed Anal. 2023;230:115383.","journal-title":"J Pharm Biomed Anal"}],"container-title":["Journal of Exposure Science &amp; Environmental Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41370-026-00884-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41370-026-00884-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41370-026-00884-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T11:09:40Z","timestamp":1788347380000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41370-026-00884-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["884"],"URL":"https:\/\/doi.org\/10.1038\/s41370-026-00884-5","relation":{},"ISSN":["1559-0631","1559-064X"],"issn-type":[{"value":"1559-0631","type":"print"},{"value":"1559-064X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"28 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None of the authors has any competing interests to declare. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the funders, institutions, the Department of Veterans Affairs, or any agencies of the United States Government.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The clinical component of the study was approved by the Central Arkansas Veterans Healthcare System Institutional Review Board (Project Number 1749012). All methods were performed in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}